Pexa-Vec: Ph I/II METROmaJX ongoing

Transgene said Institut Bergonié (Bordeaux, France) began the Phase II part of the investigator-led, open-label, French Phase Ib/II METROmaJX trial to compare cyclophosphamide plus IV Pexa-Vec on days...